Hair disorders in cancer survivors.

Abstract

With increasing survival rates across all cancers, survivors represent a growing population that is frequently affected by persistent or permanent hair growth disorders as a result of systemic therapies, radiotherapy, surgical procedures, and therapeutic transplants. These hair disorders include persistent chemotherapy-induced alopecia, persistent radiotherapy-induced alopecia, endocrine therapy-induced alopecia and hirsutism, postsurgery alopecia and localized hypertrichosis, and persistent stem cell transplantation and targeted therapy-induced alopecia. The information contained in this continuing medical education series should facilitate a better understanding on hair disorders in cancer survivors so that adequate support and therapies may be provided.

• Authors: Azael Freites-Martinez, Jerry Shapiro, Corina van den Hurk, Shari Goldfarb, Joaquin J Jimenez, Anthony M Rossi, Ralf Paus, Mario E Lacouture
• Journal: Journal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 80 Issue 5 Pg. 1199-1213 (May 2019) ISSN: 1097-6787 [Electronic] United States
• PMID: 29660423 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2018 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Chemical References

• Antineoplastic Agents

Topics

• Alopecia (etiology, pathology, therapy)
• Antineoplastic Agents (adverse effects)
• Cancer Survivors (psychology)
• Hair Diseases (etiology, therapy)
• Hirsutism (chemically induced, therapy)
• Humans
• Hypertrichosis (etiology, therapy)
• Quality of Life
• Radiotherapy (adverse effects)